National Institute for Health Research funded project will study non-pharmacological interventions for antipsychotic-induced weight gain
A new study explores ways of managing excessive weight gain in patients treated with antipsychotics for mental health problems like schizophrenia. The project, known as RESOLVE and funded by the National Institute for Health Research (NIHR), will study non-pharmacological interventions for antipsychotic-induced weight gain in people living with severe mental illness (SMI) by working directly with patients to understand and explain how, why, for whom, and in what contexts non-pharmacological interventions could help service users to manage antipsychotic-induced weight gain.
‘RESOLVE study could provide a solution to antipsychotic weight gain that could benefit individuals with psychosis and schizophrenia.’
Read More..
Up to 80% of people with schizophrenia or bipolar disorder are overweight or obese. Weight gains of up to 33kg have been reported with antipsychotics.Read More..
This weight gain has devastating consequences: life expectancy is reduced by 20 years in people with schizophrenia, partly related to the consequences of this weight gain. Diabetes has been reported to be a major issue with second-generation antipsychotics.
In RESOLVE, the researchers will combine literature that has been written about the subject.
The team will also interview volunteers, both people who have suffered from the weight and healthcare staff involved to understand their lived experience of weight gain. The team also wanted to find out what works to help manage the weight.
At the end of the project, the team plans to develop guidance for service users and practitioners on the best ways to treat and manage weight gain.
Advertisement
One member of the RESOLVE Lived Experience Advisory Group said: “The RESOLVE study could provide a tailored solution to my antipsychotic weight gain, that could benefit my unique needs as an individual.”
Advertisement
Source-Medindia